Modulation of beta1-integrins on hemopoietic progenitor cells after allergen challenge in asthmatic subjects

J Allergy Clin Immunol. 2008 Oct;122(4):803-810. doi: 10.1016/j.jaci.2008.07.021. Epub 2008 Aug 28.

Abstract

Background: Mobilization of hemopoietic progenitor cells from the bone marrow (BM) is a feature of inflammatory asthmatic responses. Understanding the mechanisms regulating progenitor cell mobilization and trafficking to the peripheral circulation might be important for the development of effective asthma therapies.

Objective: We investigated the role of adhesion molecules in the mobilization of hemopoietic progenitor cells from the BM during an allergen-induced asthmatic response.

Methods: BM and peripheral blood samples were obtained from dual-responders with mild asthma before and at several time points after allergen challenge. Fluctuations in expression and adhesive properties of beta1- and beta2-integrins on CD34(+)CD45(+) progenitor cells were assessed by using flow cytometry and adhesion to protein-coated wells, respectively.

Results: On BM-derived CD34(+)CD45(+) cells, expression of very late antigen (VLA) 4, but not VLA-5 or Mac-1, decreased significantly 24 hours after allergen challenge and had begun to recover by 48 hours after challenge. In peripheral blood allergen challenge induced a significant decrease in VLA-4 levels after 6 hours, which had not recovered by 96 hours after challenge. Similarly, VLA-5 expression decreased, most prominently at 72 to 96 hours after allergen challenge. In contrast, Mac-1 levels did not change. Chemokine-stimulated adhesion of BM-derived CD34(+)CD45(+) cells to fibronectin was significantly attenuated 24 hours after challenge. Furthermore, adhesion to fibronectin and vascular cell adhesion molecule 1 was greatly reduced by anti-VLA-4 or anti-VLA-5 antibodies.

Conclusions: Preferential downregulation of beta1-integrin expression on progenitor cells can reduce the tethering forces to BM components, thus facilitating their egress to the peripheral circulation during an allergic inflammatory response.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Allergens / immunology
  • Allergens / pharmacology*
  • Antigens, CD34 / immunology
  • Antigens, CD34 / metabolism
  • Asthma / immunology
  • Asthma / metabolism*
  • Bone Marrow / immunology
  • Bone Marrow / metabolism
  • CD18 Antigens / biosynthesis
  • CD18 Antigens / immunology
  • Cell Adhesion / drug effects
  • Cell Adhesion / immunology
  • Cells, Cultured
  • Chemokines / immunology
  • Chemokines / metabolism
  • Chemokines / pharmacology
  • Female
  • Fibronectins / immunology
  • Fibronectins / metabolism
  • Gene Expression Regulation / drug effects*
  • Gene Expression Regulation / immunology
  • Hematopoietic Stem Cell Mobilization
  • Hematopoietic Stem Cells / immunology
  • Hematopoietic Stem Cells / metabolism*
  • Humans
  • Inflammation / immunology
  • Inflammation / metabolism
  • Integrin alpha4beta1 / immunology
  • Integrin alpha4beta1 / metabolism
  • Integrin alpha5beta1 / immunology
  • Integrin alpha5beta1 / metabolism
  • Integrin beta1 / biosynthesis*
  • Integrin beta1 / immunology
  • Leukocyte Common Antigens / immunology
  • Leukocyte Common Antigens / metabolism
  • Macrophage-1 Antigen / immunology
  • Macrophage-1 Antigen / metabolism
  • Male
  • Middle Aged

Substances

  • Allergens
  • Antigens, CD34
  • CD18 Antigens
  • Chemokines
  • Fibronectins
  • Integrin alpha4beta1
  • Integrin alpha5beta1
  • Integrin beta1
  • Macrophage-1 Antigen
  • Leukocyte Common Antigens
  • PTPRC protein, human